Editorial
 REVISED NORMS FOR ISSUE OF PATENTS   
 Wednesday, August 27, 2014 
 The Section 3(d) of the amended Indian Patent Act of 2005 is a key safeguard against ever greening of a drug patent by the inventor companies by making some incremental changes to the original molecule. 
  Past Editorial...  
TODAY'S NEWS
17:00  [IST]US FDA approves Elelyso for injection for paediatric indication to treat type 1 Gaucher disease
16:00  [IST]National Institutes of Health issues final genomic data sharing policy
15:00  [IST]EU grants orphan drug status to Innate Pharma's IPH4102 to treat cutaneous T-cell lymphoma
14:00  [IST]Amerigen, Menovo ink pact to develop generic pharmaceuticals for US market
13:00  [IST]Chinese FDA approves DC Bead for liver cancer treatment
12:00  [IST]NIH awards $300,000 grant to Acura Pharma for phase I development of Limitx abuse deterrent technology
more news >>
TOP NEWS
08:00  [IST]MSF urges BMS to make daclatasvir accessible in low-and middle-income countries
08:00  [IST]Andhra, Telegana to begin counselling for medical colleges from August 30
08:00  [IST]Karnataka wary of losing investments in pharma to AP, Telangana, and Tamil Nadu
08:00  [IST]DICs need to be effective to generate awareness about ADRs among patients to avoid tragedies: Experts
08:00  [IST]Pharma cos look up to solar power to stall power crisis impacting production plants
08:00  [IST]Wholesalers in UP complains against Torrent to CCI for withholding supplies
more news >>
YESTERDAY'S NEWS
18:00  [IST]US FDA grants priority review status for ivabradine to treat chronic heart failure
17:00  [IST]FDNA, LMD partner to offer online access to leading dysmorphology database
16:50  [IST]Metropolis launches Multiplex PCR test to detect any of seven diseases causing fever
16:30  [IST]IFSO selects Dr Makam Ramesh of Vikram Hospital to demonstrate live bariatric surgery
16:00  [IST]Beigene initiates phase I study of BGB-3111 for cancer treatment
15:00  [IST]TxCell gets 5 new patents in US, Asia & Australia for core technology and ASTrIA platform since Jan 2014
more news >>
INTERVIEW  
KSPC works out strategies with Kerala govt to enforce Section 42 of Pharmacy Act in State
B Rajan, president of KSPC
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the union health ministry's recent move to increase the number of drugs covered under the national list of essential medicines (NLEM) justified?
 
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
Copyright © 2010 Saffron Media Pvt. Ltd |